A new study reports that low vitamin D levels are associated with increased morbidity and severity of IBD. A number of issues must now be addressed to enable the optimal design of interventional studies to test whether vitamin D supplementation can improve outcomes in this disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ananthakrishnan, A. N. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12, 205–217 (2015).
Cantorna, M. T. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch. Biochem. Biophys. 523, 103–106 (2012).
Kabbani, T. A. et al. Association of vitamin D level with clinical status in inflammatory bowel disease: a 5-year longitudinal study. Am. J. Gastroenterol. http://dx.doi.org/10.1038/ajg.2016.53 (2016).
Raftery, T. & O'Sullivan, M. Optimal vitamin D levels in Crohn's disease: a review. Proc. Nutr. Soc. 74, 56–66 (2015).
Miheller, P. et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm. Bowel Dis. 15, 1656–1662 (2009).
Yang, L. et al. Therapeutic effect of vitamin D supplementation in a pilot study of Crohn's patients. Clin. Translat. Gastroenterol. 4, e33 (2013).
Jorgensen, S. P. et al. Clinical trial: vitamin D3 treatment in Crohn's disease — a randomized double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 32, 377–383 (2010).
Ooi, J. H., Li, Y., Rogers, C. J. & Cantorna, M. T. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J. Nutr. 143, 1679–1686 (2013).
Bruce, D., Yu, S., Ooi, J. H. & Cantorna, M. T. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23, 519–528 (2011).
Chen, J., Waddell, A., Lin, Y. D. & Cantorna, M. T. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal Immunol. 8, 618–626 (2015).
Acknowledgements
Work in the Cantorna laboratory was supported by the NIH/National Institute of Neurological Disorders and Stroke NS067563 and National Center for Complementary and Alternative Medicine and the Office of Dietary Supplements AT005378.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Cantorna, M. Vitamin D and IBD: moving towards clinical trials. Nat Rev Gastroenterol Hepatol 13, 322–323 (2016). https://doi.org/10.1038/nrgastro.2016.72
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2016.72
This article is cited by
-
Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis
European Journal of Nutrition (2022)